Code Biotherapeutics Alternatives & Competitors
12 companies similar to Code Biotherapeutics — Pioneering targeted delivery of precision genetic medicines
Adcentrx Therapeutics
Merging Chemistry and Biology to Benefit the Lives of Patients
San Diego, United States
Endeavor BioMedicines
Boldly pursuing development of transformational medicines that may restore hope for patien...
San Diego, United States
Vertero Therapeutics, Inc.
Pioneering science beyond the brain to treat neurodegenerative diseases at their source
Woburn, United States
Dewpoint Therapeutics
Translating condensate biology into medicine.
Boston, United States
Track all Code Biotherapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
SeaBeLife Biotech
Solutions to deprogram cell death : A breakthrough innovation to treat and prevent severe...
France
Kernal Biologics
KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...
Cambridge, United States
BIORCHESTRA Co., Ltd.
We develop novel RNA-based therapeutics that will be able to bring about a paradigm shift...
Cambridge, United States
Santa Ana Bio, Inc.
Precision medicines for serious immune mediated diseases.
Alameda, United States
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Bloomsbury Genetic Therapies
Dedicated to delivering the promise of gene therapy
London, United Kingdom
AIRNA
The next generation of RNA editing therapeutics
Cambridge, United States
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
About Code Biotherapeutics
Pioneering targeted delivery of precision genetic medicines
Development of genetic medicines, Non-viral DNA delivery technology, Research in rare diseases
Healthcare providers, Patients with life-threatening diseases, Biopharma partners, Research institutions
Precision Genetic Medicines, Gene Therapy, Genetic Diseases, Non-viral Delivery, 3DNA Platform, Duchenne Muscular Dystrophy, Synthetic DNA, Targeted Delivery, Re-dosability, Bioavailability, Vector Manufacturing, Rare Diseases, Internal Pipeline, Targeted Non-viral Gene Therapies, Biotechnology Partnerships
B2B, B2D, Platform
Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Code Biotherapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Code Biotherapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.